NCT03272100 is a clinical trial of flap in Bone Involvement in Diseases Classified Elsewhere, sponsored by University of Firenze and Siena, Napoli, Italy.

Who is sponsoring NCT03272100?

NCT03272100 is sponsored by University of Firenze and Siena, Napoli, Italy.

What drugs are being tested in NCT03272100?

Interventions in NCT03272100: flap.

What condition does NCT03272100 study?

NCT03272100 studies Bone Involvement in Diseases Classified Elsewhere.

Is NCT03272100 still recruiting?

NCT03272100 is currently completed. Last updated 5 September 2017.

Last reviewed 2017-09-05 · How we verify

NCT03272100

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Two Different Flap Designs for Sinus Floor Elevation

Completed Last updated 5 September 2017

What this trial tests

trial testing flap in Bone Involvement in Diseases Classified Elsewhere in 16 participants. Completed in 1 August 2017.

Timeline

1 April 2013

Primary endpoint
1 August 2017

1 August 2017

Quick facts

Lead sponsor	University of Firenze and Siena, Napoli, Italy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	16
Start date	1 April 2013
Primary completion	1 August 2017
Estimated completion	1 August 2017
Sites	2 locations across Italy

Drugs / interventions tested

flap

Conditions studied

Bone Involvement in Diseases Classified Elsewhere — all drugs for Bone Involvement in Diseases Classified Elsewhere →

Sponsor

University of Firenze and Siena, Napoli, Italy

Who can join

18 and older, any sex, with Bone Involvement in Diseases Classified Elsewhere. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is assumed that the reduction of the flap dimension could provide a reduction of surgical time, post surgical complications and patient's discomfort when compared with the traditional surgical approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of flap

Trials testing the same drug.

NCT03167463 — Stentless Endoscopic Transnasal Transseptal Choanoplasty · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03272100 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Firenze and Siena, Napoli, Italy
Last refreshed: 5 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03272100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing